NEWS
News Articles
Seven appointed to Georgia commission overseeing new medical marijuana program
Georgia’s rollout of legislation legalizing the growth of marijuana for medicinal use and the manufacture and sale of cannabis oil produced from the leaf crop can now begin, more than four months after the law took effect. Gov. Brian Kemp has named Dr. Christopher Edwards, principal surgeon at the Atlanta Neurological & Spine Institute, to chair…
Read MoreGeoVax Vaccine Selected to Participate in Development of Potential HIV Functional Cure
Clinical Trial Expected to Commence in Early 2020 ATLANTA, GA, November 13, 2019 – GeoVax Labs, Inc. (OTCQB: GOVX) announced today its participation in a collaborative effort led by researchers at the University of California, San Francisco (UCSF), to develop a combinational therapy aimed at inducing remission in HIV-positive individuals (a “functional cure”). The studies will be…
Read MoreCovanos Named Platinum Winner At Cleveland Clinic’s 2019 Medical Innovation Summit AMP’D Arena Competition
ATLANTA, Oct. 31, 2019 /PRNewswire/ — Covanos, Inc., an Atlanta-based private medical technology company, was named the Platinum Winner of the AMP’D Arena Pitch Competition at the 2019 Medical Innovation Summit, organized by Cleveland Clinic and co-sponsored by the Wallace H. Coulter Foundation. The Company’s first product-in-development, C-HEART is a PC-based software product that uses proprietary advances in…
Read MoreClearside Biomedical Announces Option Exercise by REGENXBIO for Global License for Use of SCS Microinjector™ in AAV Gene Therapy Delivery
ALPHARETTA, Ga., Oct. 30, 2019 (GLOBE NEWSWIRE) — Clearside Biomedical, Inc. (Nasdaq: CLSD), a biopharmaceutical company dedicated to developing and delivering treatments that restore and preserve vision for people with serious back of the eye diseases, announced today that REGENXBIO Inc. (Nasdaq: RGNX) has exercised its option under the previously announced option and license agreement to…
Read MoreGeorgia Bio Statement on BD Sterilization Plant In Georgia
Closure May Lead to Medical Device Shortage & Impact Patients October 25, 2019 06:06 PM Eastern Daylight Time ATLANTA–(BUSINESS WIRE)–Georgia Bio member companies are dedicated to improving patients’ lives-enhancing patient safety and expanding patient access to innovative treatments. Public health and environmental protection are central to the values of the life sciences community. Our member…
Read MoreGeoVax Vaccine To Be Used in a Phase 1 Trial of Genetically Modified Autologous Cell Therapy for HIV
IND Application Submitted to FDA for Phase 1 Trial ATLANTA, GA, October 24, 2019 – GeoVax Labs, Inc. (OTCQB: GOVX) announced today its participation in a planned clinical trial led by researchers at American Gene Technologies (AGT) (www.americangene.com), to develop a therapy aimed at eliminating HIV from infected people. On October 18, 2019, AGT announced the submission…
Read More